Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GenHevac-B
- Development stage
- Phase 4
- Lead developer
- Sanofi
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Administration
- Intramuscular, Intradermal
01
Overview
GenHevac-B is a recombinant hepatitis B vaccine that contains pre-S2 and S antigens of the Hepatitis B virus. It is designed to stimulate the immune system to produce anti-HBs antibodies, thereby providing protection against Hepatitis B virus infection. The vaccine has been investigated for both prophylactic use in HIV-infected patients, where standard vaccination protocols are often less effective, and for therapeutic purposes in individuals with chronic Hepatitis B infection, including inactive HBsAg carriers and those in the immune tolerant phase of chronic HBV infection.
- Brand names
- GenHevac-B
- Other names
- Genevac-B
02
Targets
BCR (B-cell receptor specific for HBsAg and pre-S2 epitopes)Hepatitis B virus pre-S2 domainHBsAg (Hepatitis B surface antigen)
Beyond the preview
Go deeper on GenHevac-B.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GenHevac-B.